OR WAIT null SECS
November 30, 2015
Multi-component coupling reactions for the generation of heterocycles in fewer steps reduced processing times, cost, and waste are attracting interest.
November 26, 2015
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.
November 05, 2015
BASF’s new multi-product amines plant in Ludwigshafen, Germany meets growing demand for amines in various applications, including pharmaceuticals.
November 02, 2015
Efficient syntheses are possible using multi-component and cross-dehydrogenative, heteroaromatic C–H silylation reactions
The Transform hydrate-able film from Lubrizol LifeSciences is compatible with a range of APIs.
Efficient syntheses are possible using multi-component and cross-dehydrogenative, heteroaromatic C-H silylation reactions.
October 23, 2015
The excipient supplier's cGMP practices have been certified as meeting EXCiPACT standards
October 20, 2015
Athenex will build two facilities for high-potency, oncology API ingredients in Chongqing, China.
October 19, 2015
Hovione is investing in specialized formulation capabilities, beginning with the acquisition of a formulation facility adjacent to the current process chemistry and particle engineering facility in Loures, Portugal, the company announced on Oct. 19, 2015. This acquisition is a strategic investment to further boost development and manufacturing capabilities for both inhalation and oral dosage forms.
October 13, 2015
Umicore is one of the largest producers of platinum APIs for anti-cancer treatment. We pride ourselves in having decades of experience in platinum group metals chemistry and high potency APIs.